close 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. Hinnavahelepingud on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Palume teil kaaluda, kas hinnavahelepingute süsteem on teile arusaadav ja kas olete valmis võtma riski, mis suure tõenäoususega on kahjumlik.
Change languageEesti
Ülevaade

MDT

86.28

-0.38%↓

A

118.38

-1.59%↓

VEEV

168.34

+1.3%↑

HQY

84.43

+1.39%↑

NEOG

9.29

-1.69%↓

MDT

86.28

-0.38%↓

A

118.38

-1.59%↓

VEEV

168.34

+1.3%↑

HQY

84.43

+1.39%↑

NEOG

9.29

-1.69%↓

MDT

86.28

-0.38%↓

A

118.38

-1.59%↓

VEEV

168.34

+1.3%↑

HQY

84.43

+1.39%↑

NEOG

9.29

-1.69%↓

MDT

86.28

-0.38%↓

A

118.38

-1.59%↓

VEEV

168.34

+1.3%↑

HQY

84.43

+1.39%↑

NEOG

9.29

-1.69%↓

MDT

86.28

-0.38%↓

A

118.38

-1.59%↓

VEEV

168.34

+1.3%↑

HQY

84.43

+1.39%↑

NEOG

9.29

-1.69%↓

Kodu・Aktsiate loetelu・Nektar Therapeutics
Search

Nektar Therapeutics

Avatud

82.4 0.62

Tugev "osta" hinnang

Hinna uuendus 16. apr 2026, 16:51 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

80.53

Max

83.41

Põhinäitajad

By Trading Economics

Sissetulek

-557K

-36M

Müük

10M

22M

Aktsiakasum

-1.29

Kasumimarginaal

-165.447

Töötajad

63

EBITDA

10M

-19M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+37.67% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. mai 2026

Turustatistika

By TradingEconomics

Turukapital

373M

2.3B

Eelmine avamishind

81.78

Eelmine sulgemishind

82.4

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

0.5949 / 0.7406 Toetus ja vastupanu

Nektar Therapeutics Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. apr 2026, 23:14 UTC

Tulu

Battery Maker CATL First-Quarter Net Rose on Strong Demand

DJ

Loe

15. apr 2026, 23:14 UTC

Tulu

Battery Maker CATL First Quarter Net Rose On Strong Demand

DJ

Loe

15. apr 2026, 17:13 UTC

Suurimad hinnamuutused turgudel

Tesla Shares Rise on Completion of AI5 Chip Design Process

DJ

Loe

15. apr 2026, 23:39 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

DJ

Loe

15. apr 2026, 23:35 UTC

Market Talk
Uudisväärsed sündmused

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

DJ

Loe

15. apr 2026, 22:41 UTC

Tulu

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

DJ

Loe

15. apr 2026, 22:38 UTC

Tulu

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

DJ

Loe

15. apr 2026, 22:15 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Loe

15. apr 2026, 22:15 UTC

Market Talk

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

DJ

Loe

15. apr 2026, 22:14 UTC

Tulu

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

DJ

Loe

15. apr 2026, 22:12 UTC

Tulu

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

DJ

Loe

15. apr 2026, 22:11 UTC

Tulu

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

DJ

Loe

15. apr 2026, 22:11 UTC

Tulu

Lens Technology Swings to Loss in 1Q>300433.SZ

DJ

Loe

15. apr 2026, 22:07 UTC

Tulu

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

DJ

Loe

15. apr 2026, 21:34 UTC

Omandamised, ülevõtmised, äriostud

Skild AI Acquires Zebra Technologies' Robotics Automation Business

DJ

Loe

15. apr 2026, 21:29 UTC

Kuumad aktsiad

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

DJ

Loe

15. apr 2026, 20:50 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

DJ

Loe

15. apr 2026, 20:30 UTC

Tulu

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

DJ

Loe

15. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Loe

15. apr 2026, 20:06 UTC

Market Talk

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

DJ

Loe

15. apr 2026, 19:46 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

DJ

Loe

15. apr 2026, 19:25 UTC

Market Talk

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

DJ

Loe

15. apr 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

DJ

Loe

15. apr 2026, 18:58 UTC

Market Talk
Uudisväärsed sündmused

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

DJ

Loe

15. apr 2026, 18:11 UTC

Omandamised, ülevõtmised, äriostud

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

DJ

Loe

15. apr 2026, 17:45 UTC

Omandamised, ülevõtmised, äriostud

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

DJ

Loe

15. apr 2026, 16:58 UTC

Tulu

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

DJ

Loe

15. apr 2026, 16:52 UTC

Tulu

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

DJ

Loe

15. apr 2026, 16:46 UTC

Market Talk
Uudisväärsed sündmused

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

DJ

Loe

15. apr 2026, 16:37 UTC

Market Talk
Tulu

Global Equities Roundup: Market Talk

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Nektar Therapeutics Prognoos

Hinnasiht

By TipRanks

37.67% tõus

12 kuu keskmine prognoos

Keskmine 114.57 USD  37.67%

Kõrge 151 USD

Madal 68 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Nektar Therapeutics 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

8 ratings

7

Osta

1

Hoia

0

Müü

Põhineb 8 analüütiku instrumendi Nektar Therapeutics aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.5949 / 0.7406Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Strong Bearish Evidence

All events are bearish.

Pikk perspektiiv

Bearish Evidence

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

MDT

Medtronic PLC

86.28

↓-0.38%

A

Agilent Technologies Inc

118.38

↓-1.59%

VEEV

Veeva Systems Inc

168.34

↑ +1.3%

HQY

HealthEquity Inc

84.43

↑ +1.39%

NEOG

Neogen Corp

9.29

↓-1.69%
help-icon Live chat